Publication

My ORCID: https://orcid.org/0009-0004-0743-5813

• Beyond the Surface: Investigating the Potential Mechanisms of Non-Motor Symptoms in Myasthenia Gravis
  

  Benqiao Wang, Dan Liu, Yingying Yang, Ruixia Zhu*
  

  European Journal of Neurology, Aug, 2025.
  

  PMID: 40726281 DOI: 110.1111/ene.70309
  

• Early Predictive Accuracy of Machine Learning for Hemorrhagic Transformation in Acute Ischemic Stroke: Systematic Review and Meta-Analysis
  

  Benqiao Wang, Bohao Jiang, Dan Liu, Ruixia Zhu*
  

  Journal of Medical Internet Research, May, 2025
  

  PMID: 40408765 DOI: 10.2196/71654
  

• The intricate dance of non-coding RNAs in myasthenia gravis pathogenesis and treatment
  

  Benqiao Wang, Ying Zhu, Dan Liu, Chunxiang Hu, Ruixia Zhu*
  

  Frontiers in Immunology, Mar, 2024
  

  PMID: 38605954 DOI: 10.3389/fimmu.2024.1342213
  

• Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases
  

  Ying Zhu#, Benqiao Wang#, Yuehan Hao, Ruixia Zhu*
  

  Frontiers in Immunology, Sep, 2023
  

  PMID: 37781409 DOI: 10.3389/fimmu.2023.1223322
  

• Comparative therapeutic efficacy and safety of first-line and second-line therapies for metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
  

  Bohao Jiang# , Benqiao Wang# , Yiming Chen, Yaang Chen, Bohan Li, Jianbin*
  

  eClinical Medicine, Feb, 2025
  

  PMID: 40104085 DOI: 110.1016/j.eclinm.2025.103129
  

• Two rare cases of primary clear cell adenocarcinoma of the urethra: clinical experience, case report and literature review
  

  Bohao Jiang# , Jiyuan Hu# , Benqiao Wang# , Xujia Liu, Ling Tong, Yitong Xu, Hao Zhang*
  

  Frontiers in Oncology, Feb, 2025
  

  PMID: 40012547 DOI: 10.3389/fonc.2025.1539312
  

• Dose-response meta-analysis on urate, gout, and the risk for Parkinson’s disease
  

  Hongtao Chang, Benqiao Wang, Yue Shi, Ruixia Zhu*
  

  NPJ Parkinson’s Disease, Nov, 2022
  

  PMID: 36418349 DOI: 10.1038/s41531-022-00433-5
  

• Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities
  

  Chi Ma, Dan Liu, Benqiao Wang, Yingying Yang, Ruixia Zhu*
  

  Frontiers in Pharmacology, May, 2024
  

  PMID: 38881870 DOI: 10.3389/fphar.2024.1370411
  

• Moderate coffee or tea consumption decreased the risk of cognitive disorders: an updated dose-response meta-analysis
  

  Ying Zhu, Chunxiang Hu, Xu Liu, Ruixia Zhu* , Benqiao Wang
  

  Nutrition reviews, July, 2023
  

  PMID: 37523229 DOI: 10.1093/nutrit/nuad089
  

  
  

#: equal contribution, *: corresponding author